Bruker (BRKR) PT Lowered to $69 at Barclays
Get Alerts BRKR Hot Sheet
Price: $57.07 -7.95%
Rating Summary:
14 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
14 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
Barclays analyst Luke Sergott lowered the price target on Bruker (NASDAQ: BRKR) to $69.00 (from $75.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Oil States International (OIS) PT Lowered to $11 at Raymond James
- Regeneron Pharma (REGN) PT Raised to $875 at Baird
- Regeneron Pharma (REGN) PT Raised to $1,020 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share